Intercept Pharmaceuticals, Inc.
NASDAQ: ICPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jerome B. Durso
- Employees
- 341
- Headquarters
- New York City, United States
- IPO year
- 2012
- Market cap
- $794.7M
- Website
- https://www.interceptpharma.com
Loading ICPT…
Loading profile data…Frequently asked questions about ICPT
What does Intercept Pharmaceuticals, Inc. (ICPT) do?
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) ag...
Where does ICPT trade?
Intercept Pharmaceuticals, Inc. (ICPT) trades on the NASDAQ Global Select.
What sector is ICPT in?
Intercept Pharmaceuticals, Inc. (ICPT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Intercept Pharmaceuticals, Inc.?
Jerome B. Durso is the chief executive officer of Intercept Pharmaceuticals, Inc. (ICPT).
Where is Intercept Pharmaceuticals, Inc. headquartered?
Intercept Pharmaceuticals, Inc. is headquartered in United States.
Does ICPT pay a dividend?
Intercept Pharmaceuticals, Inc. (ICPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ICPT go public?
Intercept Pharmaceuticals, Inc. (ICPT) completed its initial public offering in 2012.